logo image
search icon
Phenobarbital Market

Phenobarbital Market Size, Share & Trends Analysis Report By Indication (Epilepsy, Neonatal seizures), By Dosage Form (Tablets, Injectable, Formulations), By Distribution channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region, And by Segment Forecasts, 2023-2031

Report ID : 2049 | Published : 2024-10-28 | Pages: 180 | Format: PDF/EXCEL

The Phenobarbital Market Size is valued at USD 1.48 Bn in 2022 and is predicted to reach USD 2.20 Bn by the year 2031 at a 4.6% CAGR during the forecast period for 2023-2031.

Phenobarbital Market

Phenobarbital acts as a central nervous system depressant. It enhances the activity of a neurotransmitter called gamma-aminobutyric acid (GABA), which inhibits brain activity. This results in a calming effect on the brain, making it useful for conditions involving seizures and anxiety. High effectiveness in the long-term management of seizures and other neurological conditions is anticipated to drive market growth during the forecast period. Furthermore, good patient compliance, as well as a large selection and simple management by healthcare practitioners, boosts the market expansion. Raising awareness among healthcare professionals is expected to propel the market growth. 

High chances of addiction and overdose are anticipated to hinder market growth. Drowsiness and vertigo are potential adverse effects which are hampering the market expansion. Moreover, strict government regulations will hamper the market growth in the coming years. The possibility of reaching emerging markets and increasing levels of field research and development creates opportunities in the market during the forecast period. 

Market Segmentation: 

The phenobarbital market is segmented on the basis of indication, dosage form and distribution channel. As per the indication, the market is segmented as epilepsy and neonatal seizures. By dosage form, the market is segmented into tablets, injectables, and formulations. On the basis of distribution channels, the market is divided into hospital pharmacies, retail pharmacies, and online pharmacies. 

Based On Indication, The Epilepsy Segment Is Accounted As A Major Contributor To The Phenobarbital Market 

The epilepsy category is expected to hold a major share in the global phenobarbital market in 2022 due to the high use of phenobarbital in status epilepticus treatment and anti-seizure management in epileptic patients, which is anticipated to drive the market growth. Phenobarbital prolongs the duration that chloride channels are open, which causes the central nervous system to become depressed.

By interacting with GABA-A receptor subunits, this effect takes place. The chloride ion gates open and remain open when phenobarbital binds to these receptors, allowing a constant flow of these ions into neuronal cells. The cell membrane becomes hyperpolarized as a result, raising the action potential threshold. This medication works well to treat seizures because of its increased action potential. 

On The Basis Of Dosage Form, The Tablets Segment Witnessed Growth At A Rapid Rate 

The tablet segment is expected to grow at a rapid rate in the global phenobarbital market owing to easier to handle and comfortable administration than another dosage forms such as injectables. Furthermore, the ease of carrying tablet dosage forms for geriatric patients is another advantage of tablet dosage forms, which is anticipated to drive the market growth. 

In The Region, The North American Phenobarbital Market Holds A Significant Revenue Share 

The North American phenobarbital market is expected to register the maximum market share in terms of revenue in the near future. This can be attributed to the greater incidence of alternative anti-convulsant medication and well-developed healthcare infrastructure. Increasing technological developments are major factors anticipated to boost the market advancement during the forecast period. High efficacy and affordability of phenobarbital are some of the factors impelling the market growth in the coming years. 

Phenobarbital Market Report Scope:

Report Attribute

Specifications

Market size value in 2022

USD 1.48 Bn

Revenue forecast in 2031

USD 2.20 Bn

Growth rate CAGR

CAGR of 4.6% from 2023 to 2031

Quantitative units

Representation of revenue in US$ Bn and CAGR from 2023 to 2031

Historic Year

2019 to 2022

Forecast Year

2023-2031

Report coverage

The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends

Segments covered

By Indication, Distribution Channel, Dosage Forms

Regional scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country scope

U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia

Competitive Landscape

Sanofi, Pfizer Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Mylan N.V., Sun Pharmaceutical Industries Ltd., Hikma Pharmaceuticals, Zydus Cadila, Lannett Company,  Inc., Strides Pharma Science Limited, Cipla Ltd., Lupin Limited, Aurobindo Pharma Limited, Torrent Pharmaceuticals Ltd., Reddy's Laboratories Ltd.

Customization scope

Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape.

Pricing and available payment methods

Explore pricing alternatives that are customized to your particular study requirements.

Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Phenobarbital Market Snapshot

Chapter 4. Global Phenobarbital Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: By Indication Estimates & Trend Analysis
5.1. By Indication, & Market Share, 2020 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By Indication:

5.2.1. Epilepsy
5.2.2. Neonatal Seizures

Chapter 6. Market Segmentation 2: By Dosage Form Estimates & Trend Analysis
6.1. By Dosage Form & Market Share, 2020 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By Dosage Form:

6.2.1. Tablets
6.2.2. Injectable Formulations

Chapter 7. Market Segmentation 3: By Distribution Channel Estimates & Trend Analysis
7.1. By Distribution Channel & Market Share, 2020 & 2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By Distribution Channel:

7.2.1. Hospital Pharmacies
7.2.2. Retail Pharmacies
7.2.3. Online Pharmacies

Chapter 8. Phenobarbital Market Segmentation 4: Regional Estimates & Trend Analysis

8.1. North America

8.1.1. North America Phenobarbital Market revenue (US$ Million) estimates and forecasts By Indication, 2019-2031
8.1.2. North America Phenobarbital Market revenue (US$ Million) estimates and forecasts By Dosage Form, 2019-2031
8.1.3. North America Phenobarbital Market revenue (US$ Million) estimates and forecasts By Distribution Channel, 2019-2031
8.1.4. North America Phenobarbital Market revenue (US$ Million) estimates and forecasts by country, 2019-2031

8.2. Europe

8.2.1. Europe Phenobarbital Market revenue (US$ Million) By Indication, 2019-2031
8.2.2. Europe Phenobarbital Market revenue (US$ Million) By Dosage Form, 2019-2031
8.2.3. Europe Phenobarbital Market revenue (US$ Million) By Distribution Channel, 2019-2031
8.2.4. Europe Phenobarbital Market revenue (US$ Million) by country, 2019-2031

8.3. Asia Pacific

8.3.1. Asia Pacific Phenobarbital Market revenue (US$ Million) By Indication, 2019-2031
8.3.2. Asia Pacific Phenobarbital Market revenue (US$ Million) By Dosage Form, 2019-2031
8.3.3. Asia Pacific Phenobarbital Market revenue (US$ Million) By Distribution Channel, 2019-2031
8.3.4. Asia Pacific Phenobarbital Market revenue (US$ Million) by country, 2019-2031

8.4. Latin America

8.4.1. Latin America Phenobarbital Market revenue (US$ Million) By Indication, (US$ Million) 2019-2031
8.4.2. Latin America Phenobarbital Market revenue (US$ Million) By Dosage Form, (US$ Million) 2019-2031
8.4.3. Latin America Phenobarbital Market revenue (US$ Million) By Distribution Channel, (US$ Million) 2019-2031
8.4.4. Latin America Phenobarbital Market revenue (US$ Million) by country, 2019-2031

8.5. Middle East & Africa

8.5.1. Middle East & Africa Phenobarbital Market revenue (US$ Million) By Indication, (US$ Million) 2019-2031
8.5.2. Middle East & Africa Phenobarbital Market revenue (US$ Million) By Dosage Form, (US$ Million) 2019-2031
8.5.3. Middle East & Africa Phenobarbital Market revenue (US$ Million) By Distribution Channel, (US$ Million) 2019-2031
8.5.4. Middle East & Africa Phenobarbital Market revenue (US$ Million) by country, 2019-2031

Chapter 9. Competitive Landscape

9.1. Major Mergers and Acquisitions/Strategic Alliances

9.2. Company Profiles


9.2.1. Sanofi
9.2.2. Pfizer Inc.
9.2.3. Novartis AG
9.2.4. Teva Pharmaceutical Industries Ltd.
9.2.5. Mylan N.V.
9.2.6. Sun Pharmaceutical Industries Ltd.
9.2.7. Hikma Pharmaceuticals
9.2.8. Zydus Cadila
9.2.9. Lannett Company, Inc.
9.2.10. Strides Pharma Science Limited
9.2.11. Cipla Ltd.
9.2.12. Lupin Limited
9.2.13. Aurobindo Pharma Limited
9.2.14. Torrent Pharmaceuticals Ltd.
9.2.15. Reddy's Laboratories Ltd..

Segmentation of Phenobarbital Market-

Phenobarbital Market By Indication-

  • Epilepsy
  • Neonatal seizures

Phenobarbital Market

Phenobarbital Market By Dosage Form-

  • Tablets
  • Injectable
  • Formulations

Phenobarbital Market By Distribution channel-

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Phenobarbital Market By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.4456

user icon
office icon
mail icon
call icon

This website is secure, and we do not share your personal information with any third party. Privacy Policy

Need Customization
Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Frequently Asked Questions

How big is the Phenobarbital Market Size?

Phenobarbital Market expected to grow at a 4.6% CAGR during the forecast period for 2023-2031

Sanofi, Pfizer Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Mylan N.V., Sun Pharmaceutical Industries Ltd., Hikma Pharmaceuticals, Zydus Ca

Our Clients

  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo

Media Citations

  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo

Growth opportunities and latent adjacency in Pharmaceuticals

Select Licence Type
$4456
$7786
$10000
$1200
Get Your GTM Strategy

Navigate market entry with channel selection, launch strategy & timeline, and pricing model support.

Equip yourself with the insights needed to develop a winning go-to-market strategy

Get real-time updates and joint control over project direction with our collaborative approach